Approval · Notice of Compliance 13887 · 2012
FOSRENOL: Notice of Compliance 13887
Issued November 21, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13887
- Date
- November 21, 2012
- Company
- Shire Canada IncLaval, QC, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the Indications and Clinical Use; Woarnings and Precautions; CLinical Trials; and Dosage and Administration sections of the Product Monograph
- Therapeutic class
- Phosphate binder
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FOSRENOL | Not yet assigned | — |
Medicinal ingredients
- LANTHANUM CARBONATE HYDRATE 250 MG per TAB
- LANTHANUM CARBONATE HYDRATE 500 MG per TAB
- LANTHANUM CARBONATE HYDRATE 750 MG per TAB
- LANTHANUM CARBONATE HYDRATE 1,000 MG per TAB